BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dailey PJ, Elbeik T, Holodniy M. Companion and complementary diagnostics for infectious diseases. Expert Rev Mol Diagn 2020;20:619-36. [PMID: 32031431 DOI: 10.1080/14737159.2020.1724784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Vogler S, Windisch F. Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections–Overview of Policies Applied in 17 European Countries. Antibiotics 2022;11:987. [DOI: 10.3390/antibiotics11080987] [Reference Citation Analysis]
2 Valla V, Alzabin S, Koukoura A, Lewis A, Nielsen AA, Vassiliadis E. Companion Diagnostics: State of the Art and New Regulations. Biomark Insights 2021;16:11772719211047763. [PMID: 34658618 DOI: 10.1177/11772719211047763] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Jørgensen JT. Companion and complementary diagnostics: an important treatment decision tool in precision medicine. Expert Review of Molecular Diagnostics 2020;20:557-9. [DOI: 10.1080/14737159.2020.1762573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]